Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that members of its management team will present at the following upcoming conferences: Cowen & Company 39th Annual Health Care ConferenceDate: Wednesday, March 13, 2019Presentation Time: 10:40 a.m. ETSpeaker: Mark Iwi